Microvascular Responses to Cardiovascular Risk Factors

Microcirculation (2010) 17, 192–205. doi: 10.1111/j.1549‐8719.2009.00015.x

[1]  H. Lijnen.  Angiogenesis and obesity. , 2008, Cardiovascular research.

[2]  K. Stokes.  Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. , 2006, Antioxidants & redox signaling.

[3]  John H. Zhang,et al.  Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. , 2004, American journal of physiology. Heart and circulatory physiology.

[4]  F. Sellke,et al.  Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. , 2009, Antioxidants & redox signaling.

[5]  G. Lip,et al.  Oxidative stress and hypertension , 2006, International journal of clinical practice.

[6]  K. Weber,et al.  Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. , 1995, Cardiovascular research.

[7]  D. Harrison,et al.  Is hypertension an immunologic disease? , 2008, Current cardiology reports.

[8]  Margaret F. Gregor,et al.  Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.

[9]  T. Gardner,et al.  Retinal angiogenesis in development and disease , 2005, Nature.

[10]  S. Bursell,et al.  Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability , 2009, Hypertension.

[11]  M. El Haouari,et al.  Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. , 2008, Blood cells, molecules & diseases.

[12]  D. Granger,et al.  Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. , 2007, Free radical biology & medicine.

[13]  R. Wolf,et al.  Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. , 1999, Hypertension.

[14]  D. R. Faber,et al.  Role of adipose tissue in haemostasis, coagulation and fibrinolysis , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[15]  L. Lerman,et al.  Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. , 2007, American journal of physiology. Heart and circulatory physiology.

[16]  J. Copeland,et al.  Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients. , 2003, Journal of diabetes and its complications.

[17]  G. Paolisso,et al.  Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.

[18]  S. Neubauer,et al.  Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Mintz,et al.  Obesity Increases Blood Pressure, Cerebral Vascular Remodeling, and Severity of Stroke in the Zucker Rat , 2009, Hypertension.

[20]  J. Akkerman,et al.  Platelet Activation by Low Density Lipoprotein and High Density Lipoprotein , 2006, Pathophysiology of Haemostasis and Thrombosis.

[21]  A. M. Lefer,et al.  Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. , 2001, American journal of physiology. Endocrinology and metabolism.

[22]  P. Balakumar,et al.  The impairment of preconditioning-mediated cardioprotection in pathological conditions. , 2009, Pharmacological research.

[23]  C. Allen,et al.  Antioxidants attenuate hyperglycaemia‐mediated brain endothelial cell dysfunction and blood–brain barrier hyperpermeability , 2009, Diabetes, obesity & metabolism.

[24]  R. L. Richardson,et al.  Adipose tissue angiogenesis. , 2004, Journal of animal science.

[25]  C. Wilcox,et al.  Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides , 2008, Pharmacological Reviews.

[26]  L. Lerman,et al.  Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia. , 2003, Atherosclerosis.

[27]  Huan Wang,et al.  The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin–angiotensin system in vivo , 2004, Journal of hypertension.

[28]  J. Panés,et al.  Reperfusion‐induced oxidative stress in diabetes: cellular and enzymatic sources , 1999, Journal of leukocyte biology.

[29]  H. Okayama,et al.  Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes , 2009, Stroke.

[30]  K. Stokes,et al.  Role of Blood Cell–Associated AT1 Receptors in the Microvascular Responses to Hypercholesterolemia , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[31]  G. Giacchetti,et al.  Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. , 2001, American journal of hypertension.

[32]  M. Remko,et al.  The role of renin-angiotensin system in prothrombotic state in essential hypertension. , 2010, Physiological research.

[33]  Margaret F. Gregor,et al.  Adipocyte stress: the endoplasmic reticulum and metabolic disease , 2007 .

[34]  T. Kadowaki,et al.  Adipogenesis in Obesity Requires Close Interplay Between Differentiating Adipocytes, Stromal Cells, and Blood Vessels , 2007, Diabetes.

[35]  C. Esmon.  Reprint of Crosstalk between inflammation and thrombosis , 2008 .

[36]  M. Menger,et al.  Role of angiotensin II in ischemia/reperfusion‐induced leukocyte‐endothelium interactions in the colon , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  P. Bath,et al.  Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study , 2001, Platelets.

[38]  B. Goldstein,et al.  Adiponectin Protects Against Angiotensin II or Tumor Necrosis Factor &agr;–Induced Endothelial Cell Monolayer Hyperpermeability: Role of cAMP/PKA Signaling , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[39]  P. Winocour,et al.  Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding , 1992, European journal of clinical investigation.

[40]  B. Goldstein,et al.  Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. , 2007, The Journal of clinical investigation.

[41]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[42]  D. Granger,et al.  Adipose tissue: A motor for the inflammation associated with obesity , 2009, IUBMB life.

[43]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[44]  M. Carr.  Diabetes mellitus: a hypercoagulable state. , 2001, Journal of diabetes and its complications.

[45]  Amir Lerman,et al.  Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia. , 2007, American journal of physiology. Heart and circulatory physiology.

[46]  K. Stokes,et al.  Cerebral Microvascular Responses to Hypercholesterolemia: Roles of NADPH Oxidase and P-Selectin , 2004, Circulation research.

[47]  P. Lenting,et al.  Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[48]  G. Leoncini,et al.  Vascular Permeability, Blood Pressure, and Organ Damage in Primary Hypertension , 2008, Hypertension Research.

[49]  C. Napoli,et al.  Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[50]  D. Granger,et al.  NAD(P)H Oxidase—Derived Superoxide Mediates Hypercholesterolemia-Induced Leukocyte—Endothelial Cell Adhesion , 2001, Circulation research.

[51]  A. M. Lefer,et al.  Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. , 2002, Diabetes.

[52]  Chang Sik Cho,et al.  Blockade of Angiotensin II Attenuates VEGF-Mediated Blood—Retinal Barrier Breakdown in Diabetic Retinopathy , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  S. Koschnick,et al.  Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. , 2001, The Journal of clinical investigation.

[54]  T. Kadowaki,et al.  In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. , 2008, The Journal of clinical investigation.

[55]  G. Plotnick,et al.  Effect of a single high-fat meal on endothelial function in healthy subjects. , 1997, The American journal of cardiology.

[56]  A. Greene.  Life and Death in the Microcirculation: a Role for Angiotensin II , 1998, Microcirculation.

[57]  K. Stokes,et al.  Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[58]  P. Brenchley,et al.  Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. , 2004, Diabetes.

[59]  K. Preissner,et al.  The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins , 2003, The Journal of experimental medicine.

[60]  D. Stengel,et al.  High Pressure Promotes Monocyte Adhesion to the Vascular Wall , 2006, Circulation research.

[61]  D. Granger,et al.  Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. , 2007, American journal of physiology. Heart and circulatory physiology.

[62]  A. Feher,et al.  Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species , 2009, Pharmacological reports : PR.

[63]  G. Lip,et al.  Does hypertension confer a hypercoagulable state? , 1998, Journal of hypertension.

[64]  G. Remuzzi,et al.  Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. , 1998, The Journal of clinical investigation.

[65]  C. DeSouza,et al.  Endothelin-1, aging and hypertension , 2008, Current opinion in cardiology.

[66]  Lisa B. Davidson,et al.  Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice. , 2009, Diabetes research and clinical practice.

[67]  J. Wilkinson-Berka.  Angiotensin and diabetic retinopathy. , 2006, The international journal of biochemistry & cell biology.

[68]  M. Sanz,et al.  Reactive oxygen species mediate angiotensin II‐induced leukocyte‐endothelial cell interactions in vivo , 2001, Journal of leukocyte biology.

[69]  R. Czekay,et al.  The leptin receptor system of human platelets , 2005, Journal of thrombosis and haemostasis : JTH.

[70]  A. Lochner,et al.  A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury , 2005, Basic Research in Cardiology.

[71]  F. Santilli,et al.  Low-Density Lipoprotein-Lowering Medication and Platelet Function , 2006, Pathophysiology of Haemostasis and Thrombosis.

[72]  K. Stokes,et al.  Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice , 2008, Stroke.

[73]  P. Tso,et al.  Diabetes exacerbates inflammatory responses to ischemia-reperfusion. , 1996, Circulation.

[74]  L. Aiello,et al.  Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation : novel mechanism for PPAR agonist ’ s effects on edema and weight gain , 2006 .

[75]  T. Mimura,et al.  Association of vitreous inflammatory factors with diabetic macular edema. , 2009, Ophthalmology.

[76]  D. Harrison,et al.  The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. , 2002, Circulation.

[77]  M. Grisham,et al.  Hypercholesterolemia enhances oxidant production in mesenteric venules exposed to Ischemia/Reperfusion. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[78]  I. Russo,et al.  Platelet dysfunction in central obesity. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[79]  C. Napoli,et al.  Microcirculation and oxidative stress , 2007, Free radical research.

[80]  C. Wahlestedt,et al.  Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[81]  D. Sane,et al.  Angiogenic growth factors and hypertension , 2004, Angiogenesis.

[82]  Y. Yamori,et al.  Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[83]  R. Loria,et al.  Platelet Aggregation in the Cerebral and Mesenterio Microcirculation of Mice With Genetically Determined Diabetes , 1981, Diabetes.

[84]  H. Motoshima,et al.  Adiponectin Suppression of High-Glucose–Induced Reactive Oxygen Species in Vascular Endothelial Cells , 2006, Diabetes.

[85]  P. Vanhoutte.  Endothelial control of vasomotor function: from health to coronary disease. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[86]  D. Granger,et al.  Modulation of the Inflammatory Response in Cardiovascular Disease , 2004, Hypertension.

[87]  George L. King,et al.  Hyperglycemia-induced oxidative stress in diabetic complications , 2004, Histochemistry and Cell Biology.

[88]  C. Napoli,et al.  Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. , 2003, Cardiovascular research.

[89]  D. Granger,et al.  CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. , 2009, American journal of physiology. Heart and circulatory physiology.

[90]  D. Stepp.  IMPACT OF OBESITY AND INSULIN RESISTANCE ON VASOMOTOR TONE: NITRIC OXIDE AND BEYOND , 2006, Clinical and experimental pharmacology & physiology.

[91]  K. Stokes,et al.  Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. , 2002, Free radical biology & medicine.

[92]  G. Dell'omo,et al.  Simvastatin, capillary permeability, and acetylcholine‐mediated vasomotion in atherosclerotic, hypercholesterolemic men , 2000, Clinical pharmacology and therapeutics.

[93]  P. Ferdinandy,et al.  Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning , 2007, Pharmacological Reviews.

[94]  R. Schmieder,et al.  Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences , 2000, Journal of hypertension.

[95]  R. Hamdy,et al.  Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. , 1998, Biochimica et biophysica acta.

[96]  Lisa B. Davidson,et al.  Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[97]  G. Singer,et al.  Inflammatory Responses Underlying the Microvascular Dysfunction Associated with Obesity and Insulin Resistance , 2007, Microcirculation.

[98]  M. Fujishima,et al.  Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. , 1998, Atherosclerosis.

[99]  C. Esmon.  Crosstalk between inflammation and thrombosis. , 2004, Maturitas.

[100]  M. El Haouari,et al.  Platelet function in hypertension. , 2009, Blood cells, molecules & diseases.

[101]  D. Granger,et al.  The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? , 2005, The Journal of physiology.

[102]  G. Schmid-Schönbein,et al.  The Inflammatory Aspect of the Microcirculation in Hypertension: Oxidative Stress, Leukocytes/Endothelial Interaction, Apoptosis , 2002, Microcirculation.